
Patricia L Morris
Examiner (ID: 4560, Phone: (571)272-0688 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1203, 1612, 1201, 1625, 1209 |
| Total Applications | 3798 |
| Issued Applications | 2697 |
| Pending Applications | 142 |
| Abandoned Applications | 965 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14684815
[patent_doc_number] => 20190241522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => NICOTINIC ACID OR ISONICOTINIC ACID COMPOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/317114
[patent_app_country] => US
[patent_app_date] => 2017-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4319
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317114
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/317114 | Nicotinic acid or isonicotinic acid compound and use thereof | Sep 7, 2017 | Issued |
Array
(
[id] => 13702483
[patent_doc_number] => 20170362196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => SUBSTITUTED BENZOTHIOPHENYL DERIVATIVES AS GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES
[patent_app_type] => utility
[patent_app_number] => 15/697867
[patent_app_country] => US
[patent_app_date] => 2017-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15697867
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/697867 | Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes | Sep 6, 2017 | Issued |
Array
(
[id] => 15245167
[patent_doc_number] => 10508096
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-17
[patent_title] => Nicotine salts, co-crystals, and salt co-crystal complexes
[patent_app_type] => utility
[patent_app_number] => 15/695227
[patent_app_country] => US
[patent_app_date] => 2017-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 20637
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15695227
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/695227 | Nicotine salts, co-crystals, and salt co-crystal complexes | Sep 4, 2017 | Issued |
Array
(
[id] => 14119143
[patent_doc_number] => 10246416
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-02
[patent_title] => Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides
[patent_app_type] => utility
[patent_app_number] => 15/692255
[patent_app_country] => US
[patent_app_date] => 2017-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11925
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15692255
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/692255 | Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides | Aug 30, 2017 | Issued |
Array
(
[id] => 15993273
[patent_doc_number] => 20200172507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => CRYSTALS OF CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/326580
[patent_app_country] => US
[patent_app_date] => 2017-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8879
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326580
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/326580 | Crystals of cyclic amine derivative and pharmaceutical use thereof | Aug 24, 2017 | Issued |
Array
(
[id] => 13079225
[patent_doc_number] => 10059670
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => Synthesis of 2-carboxamide cycloamino urea derivatives
[patent_app_type] => utility
[patent_app_number] => 15/684419
[patent_app_country] => US
[patent_app_date] => 2017-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6993
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 251
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15684419
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/684419 | Synthesis of 2-carboxamide cycloamino urea derivatives | Aug 22, 2017 | Issued |
Array
(
[id] => 12884896
[patent_doc_number] => 20180186807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
[patent_app_type] => utility
[patent_app_number] => 15/680794
[patent_app_country] => US
[patent_app_date] => 2017-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13063
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 287
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15680794
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/680794 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | Aug 17, 2017 | Abandoned |
Array
(
[id] => 12151443
[patent_doc_number] => 20180022708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'PROCESSES FOR PREPARING ASK1 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/680024
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 29449
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15680024
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/680024 | Processes for preparing ASK1 inhibitors | Aug 16, 2017 | Issued |
Array
(
[id] => 12205779
[patent_doc_number] => 20180051005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'THERAPEUTIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/680041
[patent_app_country] => US
[patent_app_date] => 2017-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 39467
[patent_no_of_claims] => 88
[patent_no_of_ind_claims] => 64
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15680041
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/680041 | Therapeutic compounds | Aug 16, 2017 | Issued |
Array
(
[id] => 15483095
[patent_doc_number] => 10556880
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-11
[patent_title] => Nicotine salts, co-crystals, and salt co-crystal complexes
[patent_app_type] => utility
[patent_app_number] => 15/671722
[patent_app_country] => US
[patent_app_date] => 2017-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 25
[patent_no_of_words] => 25561
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15671722
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/671722 | Nicotine salts, co-crystals, and salt co-crystal complexes | Aug 7, 2017 | Issued |
Array
(
[id] => 16564242
[patent_doc_number] => 10889600
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => Boron-containing compounds
[patent_app_type] => utility
[patent_app_number] => 16/322372
[patent_app_country] => US
[patent_app_date] => 2017-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18608
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322372
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/322372 | Boron-containing compounds | Aug 2, 2017 | Issued |
Array
(
[id] => 14684915
[patent_doc_number] => 20190241572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => GALUNISERTIB CRYSTALLINE FORM, PREPARATION METHOD THEREOF AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/315242
[patent_app_country] => US
[patent_app_date] => 2017-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315242 | Galunisertib crystalline form, preparation method thereof and use thereof | Jul 20, 2017 | Issued |
Array
(
[id] => 14684915
[patent_doc_number] => 20190241572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => GALUNISERTIB CRYSTALLINE FORM, PREPARATION METHOD THEREOF AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/315242
[patent_app_country] => US
[patent_app_date] => 2017-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315242 | Galunisertib crystalline form, preparation method thereof and use thereof | Jul 20, 2017 | Issued |
Array
(
[id] => 14684915
[patent_doc_number] => 20190241572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => GALUNISERTIB CRYSTALLINE FORM, PREPARATION METHOD THEREOF AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/315242
[patent_app_country] => US
[patent_app_date] => 2017-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315242 | Galunisertib crystalline form, preparation method thereof and use thereof | Jul 20, 2017 | Issued |
Array
(
[id] => 14684915
[patent_doc_number] => 20190241572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => GALUNISERTIB CRYSTALLINE FORM, PREPARATION METHOD THEREOF AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/315242
[patent_app_country] => US
[patent_app_date] => 2017-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315242 | Galunisertib crystalline form, preparation method thereof and use thereof | Jul 20, 2017 | Issued |
Array
(
[id] => 16169432
[patent_doc_number] => 10710980
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Aminopyridine derivatives and their use as selective ALK-2 inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/318250
[patent_app_country] => US
[patent_app_date] => 2017-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 19
[patent_no_of_words] => 31969
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318250
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/318250 | Aminopyridine derivatives and their use as selective ALK-2 inhibitors | Jul 17, 2017 | Issued |
Array
(
[id] => 12138181
[patent_doc_number] => 20180016264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-18
[patent_title] => 'SALT FORMS OF 4-CYANO-N-(2-(4,4-DIMETHYLCYCLOHEX-1-EN-1-YL)-6-(2,2,6,6-TETRAMETHYLTETRAHYDRO-2H-PYRAN-4-YL)PYRIDIN-3-YL)-1H-IMIDAZOLE-2-CARBOXAMIDE'
[patent_app_type] => utility
[patent_app_number] => 15/651829
[patent_app_country] => US
[patent_app_date] => 2017-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 8125
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15651829
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/651829 | Salt forms of 4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide | Jul 16, 2017 | Issued |
Array
(
[id] => 12001713
[patent_doc_number] => 20170305864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'HETEROCYCLIC COMPOUNDS AS PESTICIDES'
[patent_app_type] => utility
[patent_app_number] => 15/645814
[patent_app_country] => US
[patent_app_date] => 2017-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 187140
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645814
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/645814 | Heterocyclic compounds as pesticides | Jul 9, 2017 | Issued |
Array
(
[id] => 12126198
[patent_doc_number] => 20180009785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'SUBSTITUTED HYDANTOIN AND THIOHYDANTOIN DERIVATIVES AS ANDROGEN RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 15/643979
[patent_app_country] => US
[patent_app_date] => 2017-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30392
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15643979
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/643979 | SUBSTITUTED HYDANTOIN AND THIOHYDANTOIN DERIVATIVES AS ANDROGEN RECEPTOR ANTAGONISTS | Jul 6, 2017 | Abandoned |
Array
(
[id] => 14684821
[patent_doc_number] => 20190241525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => METHODS FOR THE SYNTHESIS OF DEUTERATED DEXTROMETHORPHAN
[patent_app_type] => utility
[patent_app_number] => 16/312439
[patent_app_country] => US
[patent_app_date] => 2017-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312439
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312439 | Methods for the synthesis of deuterated dextromethorphan | Jul 2, 2017 | Issued |